Top Biotechnology companies in Netherlands by Operating Income
Netherlands
# |
Name |
Operating Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 445.25 M
|
Dec. 31, 2023 | USD 44.64 | 0.29% |
|
Netherlands |
|
| 2 |
USD -4.88 M
|
Dec. 31, 2023 | USD 8.76 | -0.46% |
|
Netherlands |
|
| 3 |
USD -35.16 M
|
Dec. 31, 2023 | USD 2.12 | -1.40% |
|
Netherlands |
|
| 4 |
USD -43.25 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
| 5 |
USD -106.97 M
|
Dec. 31, 2023 | USD 17.60 | -0.73% |
|
Netherlands |
|
| 6 |
USD -126.93 M
|
Dec. 31, 2023 | USD 27.61 | 1.08% |
|
Netherlands |
|
| 7 |
USD -156.55 M
|
Dec. 31, 2023 | USD 40.94 | -1.52% |
|
Netherlands |
|
| 8 |
USD -165.73 M
|
Dec. 31, 2023 | USD 22.29 | 2.39% |
|
Netherlands |
|
| 9 |
USD -282.87 M
|
Dec. 31, 2023 | USD 15.74 | -0.32% |
|
Netherlands |
|
| 10 |
USD -425.05 M
|
Dec. 31, 2023 | USD 662.53 | -0.67% |
|
Netherlands |
Frequently Asked Questions
-
Which Biotechnology company in Netherlands has the highest Operating Income ?
The Biotechnology company in Netherlands with the highest Operating Income is Qiagen N.V. (NYSE: QGEN) at USD 445.25 M.
-
Which Biotechnology company in Netherlands has the lowest Operating Income ?
The Biotechnology company in Netherlands with the lowest Operating Income is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD -425.05 M.
-
What are the top 10 Biotechnology companies in Netherlands by Operating Income ?
The top 10 Biotechnology companies in Netherlands by Operating Income are Qiagen N.V., Pharming Group N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V., Pharvaris N.V., Koninklijke Philips N.V., Merus N.V., NewAmsterdam Pharma Company N.V., uniQure N.V. and argenx SE.
-
What are the bottom 10 Biotechnology companies in Netherlands by Operating Income ?
The bottom 10 Biotechnology companies in Netherlands by Operating Income are argenx SE, uniQure N.V., NewAmsterdam Pharma Company N.V., Merus N.V., Koninklijke Philips N.V., Pharvaris N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., Pharming Group N.V. and Qiagen N.V..
